Delaying radiation 50 days or more after surgery in patients with head and neck cancer is associated with increased overall mortality.


In patients with hypopharyngeal and laryngeal cancers, the number of metastatic lymph nodes is independently associated with mortality, according to a recent study.
A recent comparative study examined whether chemotherapy alone is as effective as adjuvant radiotherapy plus chemotherapy in patients with high-risk grade 2 glioma.
Survivors of thyroid cancer who were younger than 40 years at diagnosis have a higher risk of developing age-related diseases compared with older patients or those who never had cancer.
For patients with oropharyngeal squamous cell carcinoma receiving transoral robotic surgery, adjuvant radiotherapy or chemoradiotherapy should be avoided if possible, according to a long-term functional and quality-of-life outcomes study.

Research in Review

A stepped care program has been deemed more cost-effective than care-as-usual in patients with head and neck cancer or lung cancer who have psychological distress, according to a recent study published in the Journal of Clinical Oncology.


Related Content

Read More

Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in The New England Journal of Medicine.

Read More

Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study published in Cancer.

Read More

The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent study. 

Read More

Subscribe to Head & Neck Cancer